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Backgrounds. Research findings suggest that themind can cause physical disease. To plan the best quality of care, general practitioner
needs to understand an individual’s health problems in physical, social, and psychological dimensions.This study sought to establish
whether adverse life events occurring in childhood and adolescence are associated with diabetes.Methods.The cohort was collected
from the health and social support (HeSSup) study—a postal follow-up survey of randomized working-aged Finns initiated in
1998. The response rate was 40.0% and the final cohort size 24057. Data on reimbursed diabetes medication during the years 1998–
2006 were obtained from the Social Insurance Institute of Finland registers. Subjects were divided into insulin, tablet, combination
therapy, and drug-naive groups togetherwith a control groupwithout diabetes.Theprevalence of childhood adversities was assessed
based on answers to six survey questions. Results. Childhood adversities showed predominant linkage to diabetes type 2 groups,
especially to the combination therapy group requiring combined insulin and tablet treatment. No connection was found between
childhood adversities and insulin use. Cumulative adversities did not markedly increase the association. Conclusions. Stressful
events in childhood are associated with diabetes combination therapy in working age. The meaning of the relationship remains
unsolved.
1. Introduction
Psychosocial factors may contribute to somatic illnesses
through a variety of mechanisms. One recently revealed
mechanism is a model based on epigenetic regulation and
inheritance. The term epigenetics usually refers to changes
in gene expression taking place without a change in the
DNA sequence [1–3]. Today, the concept implies two main
mechanisms: DNAmethylation of cytosine bases and histone
modification via acetylation and phosphorylation, which
cause changes in gene activity. With chromosome dupli-
cation, such changes may be transferred to the ova or
sperm. Childhood abuse, for example, has been shown to
cause epigenetic changes in the expression of glucocorticoid
receptors in the adult brain [4, 5]. As a result, the number
of glucocorticoid receptors is reduced, this increasing the
secretion of cortisol. This predisposes the individual to insu-
lin resistance in adulthood.
Stress can be defined as any condition which seriously
perturbs the physiological or psychological homeostasis of
an organism [6]. Adversities ordinarily cause stress for a
child [7, 8]. Stress caused by childhood events is usually by
nature psychosocial. In such situations, the interpretation of
what is experienced as stressful takes place in the brain [9].
Memory plays an essential role in psychosocial stress. During
evolution, the ability to recall prior dangerous events has been
a useful trait. We now know that traumatic childhood events
affect the brain and thus an earlier experience may trigger a
stress response later in life [5].
The significance of stress in the development of diseases
has been described by, among others, the allostasis model.
Allostasis refers to the homeostasis of stress or the regulation
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of stress in the body, enabling the individual to adapt to the
stress factor [10]. When the body experiences long-lasting
and too frequently recurring situations activating the stress
response, a disease state may develop.This overload has long-
lasting effects on the body’smetabolic systems: endocrinolog-
ical, immunological, and neurological. Studies have shown
that these three systems are anatomically and functionally
interlinked [11–13]. In consequence of this overload, the body
is predisposed to a number of diseases common in the world
today, one of them being diabetes type 2. For example, data
from one longitudinal clinical study show that the prevalence
of cardiovascular disease and diabetes is higher in later life
among individuals separated from their families in early
childhood during the Second World War [14].
Cortisol is an important hormone, which mediates the
effects of stress in the endocrinological system. Hypothala-
mus, pituitary gland, and adrenal gland, that is, the HPA
axis, regulate its secretion. Several brain areas, for exam-
ple, the amygdala and hippocampus, which are activated
during psychosocial stress, influence the hypothalamus [15].
Cortisol functions as an antagonist to insulin and alleviates
the immune response [9, 16]. Epigenetic regulation of the
receptor gene NR3C1 leads to a decrease in glucocorticoid
receptors, which in turn reduces the feedback from the
HPA axis and thus increases cortisol secretion [4, 5]. This
predisposes, among other things, to insulin resistance in
adulthood.
When the immune system is activated, inflammation-
mediating cytokines are secreted in the stress response. By
inhibiting these cytokines, cortisol acts to restore the home-
ostasis of the organism after the stressful condition has sub-
sided [10]. Without this effect, the inflammatory state would
continue to destroy the organism [17]. Measured by CRP lev-
els, as a result of earlier adverse childhood events the immune
defence is more active in adulthood [18]. Chronic stress
exposure may lead to lower cortisol levels, hypocortisolism,
with increased Th1-mediated immune defence and an ele-
vated risk ofTh1-mediated autoimmune disease [19]. Cortisol
reduces the function of the Th1-mediated immune defence
[20]. Diabetes type 1 is mainly a Th1-mediated disease.
As the neurologic system is activated as the most imme-
diate response to a stressful event, sympathetic activation
induces the secretion of catecholamines in the cortex of the
adrenal glands (the fight-or-flight response, that is, the acute
stress response). Neurons also secrete neuropeptides and thus
speed up recovery from the stress response and enhance
adaptation to it [21, 22].
To plan the best quality of care, the general practitioner
needs to understand an individual’s health problems in
physical, social, and psychological dimensions [23].
Today, nearly half a million Finns are estimated to have
diabetes and the number is still steadily increasing [24].
There are only few high quality population studies on the
state of diabetes care in Finland [25]. The management of
the diabetes is emerging. During childhood, stress factors
may influence the developing hormonal, neurological, and
immunological systems and hence also their functioning in
adulthood. Recent research findings suggest that stressful
events can increase the risk of developing the difficult-to-
manage form of diabetes, type 1 [26]. More researches on this
aspect are needed.
In this population study, the aim was to establish whether
there is a connection between stressful events during child-
hood and diabetes. The study hypothesis was that childhood
adversities increase the prevalence of diabetes and come up
in diabetes care.
2. Materials and Methods
2.1. Material. The health and social support study (HeS-
Sup) was a prospective follow-up study of the psychosocial
health of the Finnish working-aged population [27, 28].
The subjects belonged to a random sample drawn from the
Finnish population register in four age groups: 20–24, 30–
34, 40–44, and 50–54. The survey was carried out by postal
questionnaire during 1998. Completed questionnaires were
returned by 25 898 individuals, giving a response rate of
40.0%. The compatibility of the HeSSup sample with the
Finnish general population was tested using official statistics,
and the conclusion was that the differences in physical health
between participants and the general population were small
[27, 28]. A follow-up questionnaire (response rate 80.2%) was
sent in 2003 to all who had responded in 1998.
The Social Insurance Institution of Finland (SII) main-
tains a nationwide database on all purchases of diabetes
medication in Finland. For the purposes of this study, data
on reimbursed diabetes medication in the period 1998–2006
were drawn from the registers of the SII and combined
with the 1998 HeSSup data. The combined sample size was
24057, the number of drop-outs being 1841. These latter were
individuals who did not grant us permission to combine
their data with national registers or such as had dropped out
because of death or hadmoved abroad.Medication purchases
were encoded with ATC codes A10A (insulin) and A10B (oral
diabetes medicine).
In the structured questionnaire, the participants were
asked a diabetes-related survey question: “has a doctor ever
told you that you have or have had diabetes?” Alternative
replies were “yes” or “no”. Those who answered “yes” in 1998
or 2003 and those who had purchased diabetes medicine
between the years 1998–2006 were classified as patients with
diabetes. All in all, the cohort included 1182 patients with
diabetes.
With the help of data from both the survey questionnaire
and the SII registers, patients with diabetes were classified
into five study groups (Figure 1), each patient with diabetes
belonging to one group only. Those using only insulin
medication (ATC code A10A) were classified into the insulin
group (𝑛 = 190). It is likely that this group would be strongly
weighted among those having diabetes type 1. People using
oral diabetes medicine (ATC code A10B) were classified into
the tablet group (𝑛 = 508) and consisted mostly of type 2
patients with diabetes.The third study group comprised those
using both insulin (A10A) and tablet-form treatment (A10B)
and was named as the combination therapy group (𝑛 = 188).
International Journal of Family Medicine 3
Random sample from the Finnish 
population register
n = 64797
Stressful childhood events 
in the 1998 survey






















Figure 1: Flow chart illustrating the formation of study groups.
The fourth study group comprised those participants who
in the 1998 survey reported having been diagnosed with
diabetes by a doctor (𝑛 = 296). In a more detailed classi-
fication, we transferred a number of cases from this group
into other groups based on their medication purchases. This
group was termed the drug-naive group, and it included
individuals who had reported themselves as patients with
diabetes either a result of a misunderstanding with their
doctor or whose condition was such that it could be treated
with lifestyle and dietary changes without medication. It is
also probable that this group included individuals who were
not receiving any treatment at all and were managing their
diabetes poorly as well as neglecting their medicine.
The control group (𝑛 = 22875) comprised individuals
who were healthy with respect to diabetes and did not belong
to any of the above-described four groups. In addition, they
had no SII-registered diabetes-related entries nor subjectively
reported diabetes in either of the surveys.
2.2. Methods. The subjects were asked to recall their child-
hood adversities in terms of the following structured ques-
tions: “did your parents divorce?”, “did your family have long-
lasting financial difficulties?”, “did serious conflicts arise in
your family?”, “were you often afraid of somemember of your
family?”, “was someone in the family seriously or chronically
ill?”, “did someone in the family have problemswith alcohol?”
The alternatives were “yes”, “no”, or “I do not know”. Only
the first two options were included in statistical analyses.The
overall impact of these variables was estimated by the number
of affirmative answers.
To confirm the reliability of responses regarding child-
hood adversities, the Cohen’s kappa coefficient (𝜅) was used
to assess associations between the 1998 and 2003 question-
naires. 𝜅 varied between 0.621 and 0.903 among participants.
The statistical significance of differences between the
diabetes groups and the controls was tested by 𝜒2 test.
Odds ratios (OR) with 95% confidence intervals (CI) were
calculated by separate multivariate logistic regression anal-
yses to measure the risk of belonging to a certain diabetes
group. Associations between childhood adversities and dia-
betes study groups compared to controls were analysed with
logistic regressionmethods as well. Each childhood adversity
variable was analysed individually with each diabetes group
as an outcome variable. Confounding factors, age, sex, Beck’s
depression inventory (BDI), body mass index (BMI), and
alcohol usage, were changed into dichotomised variables for
logistic regression and taken into account in the analyses
(Table 1). The two youngest age groups (20–25 and 30–35)
were merged into a group and the two oldest age groups
(40–45 and 50–55) into another group. Weekly alcohol usage
was likewise dichotomised into two groups: the “usage of
0–22 g” group and the “usage of over 22 g” group. The
accumulation variable of childhood adversities was made by
dichotomizing respondents into the 0-1 adversities and the
2–6 adversities groups. Analyses were made using the SAS
system for Windows, release 9.2.
Respondents’ demographic characteristics, age, sex, BMI,
maximum BMI, BDI, smoking, and alcohol usage, are pre-
sented in Table 1 as frequency distributions.
The concurrent joint Ethics Committee of the University
of Turku and Turku University Central Hospital considered
approval not necessary for a normal cohort study, but all
participants were requested to sign a consent form containing
information on the study and to grant permission to allow
subsequent studies with the same data set and the possibility
to link up with national health registries.
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Table 1: Frequency distributions of the diabetes study groups and the control group in terms of respondents’ demographic characteristics.
Control group Insulin group Tablet group Combinationtherapy group Drug-naive group
𝑛 = 22 875 𝑛 = 190 𝑛 = 508 𝑛 = 188 𝑛 = 296
% % % % %
Gender
Female 59.4 52.1 46.5 42.6 63.9
Male 40.6 47.9 53.5 57.4 36.1
Age in 1998
20–25 and 30–35 51.9 59.5 15.5 13.8 32.4
40–45 and 50–55 48.1 40.5 84.5 86.2 67.6
BMI in 1998
Under 25 62.9 56.6 16.4 9.7 36.0
25 or over 37.1 43.4 83.6 90.3 64.0
BMI maximum in 1998
Under 25 46.7 35.8 9.6 4.4 22.5
25 or over 53.3 64.2 90.4 95.6 77.5
BDI in 1998
Under 19 95.7 93.0 90.0 88.7 87.8
19 or over 4.3 7.0 10.0 11.3 12.2
Smoking in 1998
Does not smoke 45.4 38.7 37.1 30.4 34.2
Smokes or has quit 54.6 61.3 62.9 69.6 65.8
Weekly drinking
0–22 g 30.4 33.2 32.9 37.4 37.2
Over 22 g 69.6 66.8 67.1 62.6 62.8
3. Results
The prevalence of childhood adversities varied among the
study subjects (Table 2). Compared to the control group,
the drug-naive group reported most childhood adversities.
Among the insulin-purchasing group (insulin group), only
a family member’s serious illness was more prevalent than
among controls (9.7 percent units). The incidence of family
members’ serious illness was also statistically significant
and 8.9–12.5 percent more prevalent in other study groups
compared to the control population.
The insulin-purchasing group reported no long-lasting
financial difficulties in childhood, whereas in other study
groups financial difficulties were statistically significantly
more prevalent than in the control group. Differences varied
between 6.4–11.3 percent units. Among the groups using oral
diabetes medicine, there had been fewer divorces than in the
control population (5.1–6.7 percent units).
A family member’s serious illness was the only childhood
adversity which statistically significantly increased the risk
of belonging to the insulin-managed diabetes group even
when confounding factors were included (OR 1.89, 95% CI
1.17–3.04) (Table 3). Other childhood adversities and their
accumulation were not connected with later-life insulin
usage.
A familymember’s serious illness statistically significantly
increased the risk of tablet-treated diabetes in adult life (OR
1.55, 95% CI 1.16–2.06). However, when confounding factors
were taken into account in logistic regression analysis, the
increase was no longer statistically significant (OR 1.24, 95%
CI 0.92–1.67) (Table 3).
A family member’s serious or chronic illness, long-
lasting financial difficulties, and having been afraid of a
family member statistically significantly increased the risk of
having combination therapy, that is, a tablet- and insulin-
treated form of diabetes later in life without controlling the
confounding factors (OR2.18, 95%CI 1.39–3.43,OR2.29, 95%
CI 1.45–3.62, and OR 1.92, 95% CI 1.08–3.40), respectively.
When they were controlled, the risks were 1.70 (1.07–2.71),
1.90 (1.19–3.04), and 1.65 (0.91–3.00), respectively (Table 3).
The connection remained statistically significant between
childhood adversities and combination therapy diabetes,
excluding the adversity of having been afraid of a family
member. An accumulation of childhood adversities increased
the risk of combination therapy diabetes (OR 1.86, 95% CI
1.03–3.38).
Having been afraid of a family member statistically sig-
nificantly increased the risk of belonging to the drug-naive
group (OR 1.64, 95% CI 1.10–2.45). However, when con-
founding factors in regression analysis were controlled, the
connection was no longer statistically significant (Table 3).
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Table 2: Occurrence of childhood adversities (%) in the diabetes study groups and the statistical significance of differences from controls.
Control
group Insulin group Tablet group
Combination
therapy group Drug-naive group
𝑛 = 22 875 𝑛 = 190 𝑛 = 508 𝑛 = 188 𝑛 = 296
% % 𝑃 value % 𝑃 value % 𝑃 value % 𝑃 value
Parental divorce 17.4 16.8 0.835 12.3 0.004 10.7 0.019 18.0 0.782
Long-lasting financial
difficulties 24.4 23.7 0.821 30.8 0.001 35.7 <0.001 33.1 0.001
Serious family conflicts 24.8 20.1 0.141 27.7 0.141 25.9 0.723 31.7 <0.001
Afraid of a family member 12.8 10.9 0.459 14.3 0.312 16.3 0.152 22.2 <0.001
Seriously or chronically ill
family member 24.9 34.6 0.002 33.8 <0.001 37.4 <0.001 36.0 <0.001
Alcohol problem of a
family member 24.0 27.3 0.293 26.5 0.192 24.7 0.817 31.8 0.008
Table 3: Summary of separate multivariate logistic regression analyses with odds ratios and 95% confidence intervals (OR; 95% CI).
Confounding factors; age, sex, Beck’s depression inventory (BDI), body mass index (BMI), and alcohol usage were included in the analyses.
Insulin group Tablet group Combination therapygroup Drug-naive group
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Parental divorce 0.85 (0.48–1.50) 1.00 (0.69–1.46) 1.16 (0.64–2.08) 1.31 (0.90–1.91)
Long-lasting financial
difficulties 0.84 (0.53–1.34) 1.04 (0.78–1.40) 1.90 (1.19–3.04) 0.96 (0.69–1.33)
Serious family conflicts 0.77 (0.45–1.33) 1.24 (0.88–1.75) 0.65 (0.36–1.18) 0.86 (0.58–1.28)
Afraid of a family member 0.85 (0.44–1.67) 0.99 (0.67–1.45) 1.65 (0.91–3.00) 1.43 (0.95–2.16)
Seriously or chronically ill
family member 1.89 (1.17–3.04) 1.24 (0.92–1.67) 1.70 (1.07–2.71) 1.09 (0.78–1.53)
Alcohol problem of a
family member 1.29 (0.79–2.11) 1.12 (0.82–1.53) 1.25 (0.75–2.06) 1.03 (0.72–1.46)
2–6 childhood adversities 0.89 (0.51–1.57) 1.36 (0.95–1.95) 1.86 (1.03–3.38) 0.70 (0.46–1.07)
4. Discussion
Childhood adversities are connected to diabetes, but in differ-
ent ways depending on the etiology of the disorder. A family
member’s serious illness showed themostmarked association
with later life onset of diabetes, whereas an accumulation of
childhood adversities was not markedly connected with the
occurrence of diabetes.
A major strength of this study was that linkage to the
SII data was successful for virtually all individuals in the
original sample. Furthermore, the registry data on medicine
purchases in Finland can be considered reliable and the data
also verifies the diagnosis of diabetes. The large sample size
ensured that conclusions drawn from the statistical analyses
cannot be attributed to random effects. To obtain reliable
information regarding an individual’s exposure status, we
analysed the kappa coefficient for every childhood adversity
and, based on the results, our conclusion was that answers
concerning childhood adversities can be considered reliable.
Two analyses of respondents and nonrespondents of theHeS-
Sup study were carried out to ensure better generalizability of
the results [27, 28].
In previous diabetes research, childhood adversities have
been connected with diabetes type 1 [19, 29, 30]. In this study,
however, no clear connection between a childhood adversity
and diabetes type 1 was found. The only clear risk factor for
diabetes type 1 (the insulin group) seemed to be a family
member’s serious or chronic illness, which may point to the
hereditary nature of the illness in the Finnish population.
On the other hand, childhood adversities would appear
to be connected to the occurrence of diabetes type 2 (tablet
group, combination therapy group, and drug-naive group).
In previous research, the connection has been regarded as
controversial [30].
Childhood adversities increased the risk of having amore
advanced form of diabetes requiring combination therapy. A
longer period of having diabetes, a poorly managed lifestyle,
tablet-treated diabetes type 2, and metabolic syndrome in
type 1 patients with diabetes are factors possibly leading to
combination therapy treatment.
In the drug-naive group, all occurrences of childhood
adversities except parental divorce were statistically signifi-
cantly prevalent compared to controls. Drug-naive patients
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with diabetes had no entries of reimbursed diabetes medica-
tion purchases in the SII registers. There is thus no objective
certainty that these participants do in fact have diabetes.
Presumably in some members of this group the diabetes is
managed by lifestyle and dietary changes only, while another
part presumably neglects to take care of their diabetes and
thusmay not even have started themedication recommended
by a doctor, or they are outside the health care system (i.e.,
unemployed and socially excluded). It is also possible that
the drug-naive group includes individuals who recall negative
life experiences better than other participants in the study.
At least, according to the BDI questionnaire, compared to
the other groups this group contained the greatest number
of depressed participants, and, as is known, people when
depressed tend to overemphasise negative life experiences in
their past [31].
It has been shown that the effects of childhood adversities
can be alleviated or even inhibited [9]. As they seem to
increase the later life risk of developing the difficult-to-
manage form of diabetes, it would be advisable to take
childhood adversities into account in considering preven-
tive health care, since the difficult-to-manage diabetes is
expensive to treat for both society and the individual. For
a general practitioner, to have a comprehensive approach to
the care of an individual and a community, it is important
to understand health problems in the individual’s physical,
psychological, social, cultural, and existential dimensions
[23]. The emphasis should be, among the other support
measures, on reducing the stress, that is, the allostatic
overload caused by childhood adversities. In efforts to moti-
vate those having the difficult-to-manage form of diabetes
to avail themselves of treatment, health-care professionals
might be better to concentrate on highlighting successes
rather than adversities as people belonging to this group
have already encountered an abundance of negative life
experiences.
The aetiology of diabetes is partly unknown. It is also pos-
sible that the aetiology underlying the condition varies within
and between diabetes groups [14]. Allostatic overload may
complicate the progress of emerging diabetes by epigenet-
ically activating or inhibiting genes. One possibility might
be that the childhood adversities may be more markedly
associated with challenging diabetes management than with
the occurrence of diabetes. The combination therapy group
may be weighted among those having more advanced or
poorly managed diabetes [25]. According to recent research,
childhood adversities are connected to poor self-care and
diabetes, type 1, management as measured by haemoglobin
A1 c concentrations [26]. As a conclusion, childhood adversi-
ties are associatedwith combined tablet and insulin-managed
diabetes. The meaning of the relationship is not clear and is a
subject for further research.
More research is warranted from the viewpoint of
patients, from patients with problems and limitations. Suc-
cessful care is the goal for both the family doctor and the
patient with history and life experience. A competent family
doctor keeps this in mind when taking care of diabetes
patients.
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